PROMETHERA BIOSCIENCES
0809.788.365 · rovalta.com · 08/11/2026
PROMETHERA BIOSCIENCES
Company — Opening of bankruptcy.
Financial year 2022 · Closed on 31/12/2022
Overview
Identity
Source · BCE/KBOPROMETHERA BIOSCIENCES is a Public limited company incorporated in 2009. Its main activity is: Other human health activities. Its registered office is in Mont-Saint-Guibert.
- Legal situation
- Opening of bankruptcy
- BCE/KBO no. / VAT
- BE 0809.788.365
- Incorporation
- 12/02/2009
- Legal form
- Public limited company
- Registered office
- Rue Granbonpré 11
1435 Mont-Saint-Guibert · WallonieSee on map - Contributed capital
- 61 705 717,00 €
- Latest accounts
- 31/12/2022
Joint committees (2)
- 200
- 218
Financials
Source · NBB, 19 filingsTrend over 14 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 55,3 k € | -99.7% | 18,1 M € | +209% | -16,6 M € | +29.9% | -23,7 M € | -57.5% | -15,1 M € |
| EBITDA | -500 k € | -103% | 17,7 M € | +176% | -23,3 M € | +21.8% | -29,8 M € | -56.0% | -19,1 M € |
| Operating result | -500 k € | -103% | 17 M € | +172% | -23,6 M € | +21.5% | -30,1 M € | -54.7% | -19,5 M € |
| Net result | -519,5 k € | -103% | 16,5 M € | +134% | -49 M € | -61.8% | -30,3 M € | -45.8% | -20,8 M € |
| Balance sheet | |||||||||
| Equity | -1,5 M € | -53.2% | -976,5 k € | +94.4% | -17,5 M € | -156% | 31,4 M € | +35.7% | 23,2 M € |
| Total assets | 4,3 M € | -1.7% | 4,4 M € | -43.2% | 7,8 M € | -84.1% | 48,7 M € | +15.6% | 42,1 M € |
| Cash | 611 € | -78.4% | 2,8 k € | -99.9% | 2,3 M € | -78.0% | 10,4 M € | -13.4% | 12,1 M € |
| Debts | 5,8 M € | +8.2% | 5,4 M € | -78.1% | 24,6 M € | +47.8% | 16,7 M € | -10.2% | 18,5 M € |
| Other | |||||||||
| Workforce | – | 6,1 ETP | -92.3% | 78,9 ETP | +13.5% | 69,5 ETP | +50.4% | 46,2 ETP | |
Board of directors
Source · NBB, accounts to 31/12/20227 active · 21 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Bruno DE KEERSMAEKER | Director23/03/2022 → 15/06/2026 | ||
| Managing director13/07/2020 → 15/06/2026Director29/10/2009 → 2015 accountsended | |||
Tak fok CHI | Director13/07/2020 → 15/06/2026 | ||
Hayashi SHINTARO | Director01/04/2020 → 15/06/2026 | ||
Edward Walter HAACK | Director31/10/2019 → 15/06/2026 | ||
Etienne SOKAL | Managing director31/10/2019 → 15/06/2026Director29/10/2009 → 2019 accountsended | ||
Reiko NAMIKAWA | Director23/11/2017 → 15/06/2026 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Dong ZIMENG | Managing director13/07/2020 → 2021 accounts | ||
Charles L. DIMMIER III | Director31/10/2019 → 2020 accounts |
Other companies at this address
Rue Granbonpré 11 1435 Mont-Saint-Guibert| Company | CBE no. |
|---|---|
Ascend Performance Materials● Active | 0810.113.316 |
| 1012.379.397 | |
AUDANE INVEST● Active | 0816.921.429 |
BiocSol● Active | 1003.683.546 |
CEDRIC CLAERHOUDT● Active | 0477.799.927 |
Cellaïon● Liquidation | 0764.522.425 |
| 0859.906.087 | |
Cronos Sud● Active | 1014.190.824 |
DE SMET AGRO● Active | 0402.951.757 |
| 0438.987.752 | |
FLEXSO BRUSSELS● Active | 0898.889.892 |
Keiro● Active | 0681.490.821 |
NOVADIP BIOSCIENCES● Active | 0535.575.602 |
PARLYM BELGIUM● Active | 1028.144.372 |
PARSMET MANAGEMENT● Active | 1025.167.858 |
TFP IMMO● Active | 1032.940.330 |
The Akkermansia Company● Active | 0664.529.083 |
THE TORREFACTORY PROJECT● Active | 0679.686.720 |
Tools4Patient● Active | 0534.842.954 |
VAT Group Ascend● Active | 1002.911.308 |
Financials
Full financial information
Source · NBB| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Consolidated accounts |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 07/07/2023 | 05/08/2022 | 23/06/2021 | 29/07/2020 | 03/06/2019 | 01/10/2018 |
| General meeting | 15/06/2023 | 06/07/2022 | 15/06/2021 | 03/07/2020 | 09/05/2019 | 01/01/9999 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 19 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2022 | 15/06/2023 | 07/07/2023 | French | |
| Abridged model | 31/12/2021 | 06/07/2022 | 05/08/2022 | French | |
| Abridged model | 31/12/2020 | 15/06/2021 | 23/06/2021 | French | |
| Abridged model | 31/12/2019 | 03/07/2020 | 29/07/2020 | French | |
| Abridged model | 31/12/2018 | 09/05/2019 | 03/06/2019 | French | |
| Consolidated accounts | 31/12/2018 | 01/01/9999 | 31/05/2019 | English | |
| Abridged model | 31/12/2017 | 17/05/2018 | 12/06/2018 | French | |
| Consolidated accounts | 31/12/2017 | 01/01/9999 | 01/10/2018 | English | |
| Abridged modelCorrection | 31/12/2016 | 11/05/2017 | 10/04/2018 | French | |
| Abridged model | 31/12/2016 | 11/05/2017 | 23/05/2017 | French | |
| Consolidated accounts | 31/12/2016 | 01/01/9999 | 18/07/2018 | English | |
| Abridged model | 31/12/2015 | 25/05/2016 | 11/08/2016 | French | |
| Abridged model | 31/12/2014 | 28/05/2015 | 08/06/2015 | French | |
| Abridged model | 31/12/2013 | 08/05/2014 | 13/05/2014 | French | |
| Abridged modelCorrection | 31/12/2012 | 15/05/2013 | 17/02/2014 | French | |
| Abridged model | 31/12/2012 | 15/05/2013 | 28/05/2013 | French | |
| Abridged model | 31/12/2011 | 10/05/2012 | 18/10/2012 | French | |
| Abridged model | 31/12/2010 | 31/05/2011 | 15/06/2011 | French | |
| Abridged model | 31/12/2009 | 17/05/2010 | 26/05/2010 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20227 active · 21 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Bruno DE KEERSMAEKER | Director23/03/2022 → 15/06/2026 | ||
| Managing director13/07/2020 → 15/06/2026Director29/10/2009 → 2015 accountsended | |||
Tak fok CHI | Director13/07/2020 → 15/06/2026 | ||
Hayashi SHINTARO | Director01/04/2020 → 15/06/2026 | ||
Edward Walter HAACK | Director31/10/2019 → 15/06/2026 | ||
Etienne SOKAL | Managing director31/10/2019 → 15/06/2026Director29/10/2009 → 2019 accountsended | ||
Reiko NAMIKAWA | Director23/11/2017 → 15/06/2026 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Dong ZIMENG | Managing director13/07/2020 → 2021 accounts | ||
Charles L. DIMMIER III | Director31/10/2019 → 2020 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates11/05/2022DEMISSIONS, NOMINATIONS
- Mandates23/02/2022DEMISSIONS, NOMINATIONS
- Restructuring09/02/2022RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Capital / shares23/02/2021OBJET - CAPITAL, ACTIONS
- Mandates10/11/2020DEMISSIONS, NOMINATIONS
- Mandates25/09/2020DEMISSIONS, NOMINATIONS
- Mandates02/09/2020CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Mandates22/06/2020DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue Granbonpré 11, 1435 Mont-Saint-GuibertCurrent | accounts 2021 → 2022 | Accounts 2022 · 2023-00219787 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| PROMETHERA BIOSCIENCESCurrent | accounts 2009 → 2022 | Accounts 2022 · 2023-00219787 |
Events
- 2022Annual accounts 2022-519,5 k €↓
- 2021Annual accounts 202116,5 M €↑
- 2020Annual accounts 2020-49 M €↓
- 2019Annual accounts 2019-30,3 M €↓
- 2018Annual accounts 2018-20,8 M €↓
- 2017Annual accounts 2017-12,2 M €↓
- 2016Annual accounts 2016-9,2 M €↓
- 2015Annual accounts 2015-6,7 M €↓
- 2014Annual accounts 2014-6,7 M €↓
- 2013Annual accounts 2013-6 M €↓
- 2012Annual accounts 2012-4,5 M €↓
- 2011Annual accounts 2011-3,5 M €↓
- 2010Annual accounts 2010-1,7 M €↓
- 2009Annual accounts 2009-551,3 k €
- 12/02/2009IncorporationPublic limited company